
doi: 10.1159/000098505
pmid: 17245084
At present, surgical separation of the vitreous from the retina (posterior vitreous detachment, PVD) is achieved by mechanical means only. However, with this technique, complete removal of the cortical vitreous from the internal limiting membrane of the retina is not feasible. As incomplete PVD and an attached vitreous cortex are associated with the progression of common retinal diseases including diabetic retinopathy and maculopathy, central retinal vein occlusion and proliferative vitreoretinopathy, induction of complete PVD is a major issue both in vitreoretinal surgery and in medical retina. This chapter focuses on current concepts of pharmacologic vitreolysis. Agents capable of altering the molecular organization of the vitreous are introduced and discussed in terms of PVD induction and liquefaction of the vitreous gel.
Vitreous Body, Treatment Outcome, Fibrinolytic Agents, Retinal Diseases, Endopeptidases, Humans, Hyaluronoglucosaminidase, Fibrinolysin, Chondroitinases and Chondroitin Lyases, Injections
Vitreous Body, Treatment Outcome, Fibrinolytic Agents, Retinal Diseases, Endopeptidases, Humans, Hyaluronoglucosaminidase, Fibrinolysin, Chondroitinases and Chondroitin Lyases, Injections
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 17 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
